These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 18805365)
1. Evaluation of bone turnover in epileptic children using oxcarbazepine. Cansu A; Yesilkaya E; Serdaroğlu A; Hirfanoğlu TL; Camurdan O; Gülbahar O; Gücüyener K; Cinaz P Pediatr Neurol; 2008 Oct; 39(4):266-71. PubMed ID: 18805365 [TBL] [Abstract][Full Text] [Related]
2. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Pack AM; Morrell MJ; Randall A; McMahon DJ; Shane E Neurology; 2008 Apr; 70(18):1586-93. PubMed ID: 18443309 [TBL] [Abstract][Full Text] [Related]
3. Bone mineral status in pediatric outpatients on antiepileptic drug monotherapy. Tekgul H; Serdaroglu G; Huseyinov A; Gökben S J Child Neurol; 2006 May; 21(5):411-4. PubMed ID: 16901447 [TBL] [Abstract][Full Text] [Related]
4. The effect of levetiracetam and oxcarbazepine monotherapy on thyroid hormones and bone metabolism in children with epilepsy: A prospective study. Shi KL; Guo JX; Zhao HM; Hong H; Yang CZ; Wu YH; Du LJ Epilepsy Behav; 2020 Dec; 113():107555. PubMed ID: 33242769 [TBL] [Abstract][Full Text] [Related]
5. Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy. Koo DL; Hwang KJ; Han SW; Kim JY; Joo EY; Shin WC; Lee HW; Seo DW; Hong SB Epilepsy Res; 2014 Mar; 108(3):442-7. PubMed ID: 24507862 [TBL] [Abstract][Full Text] [Related]
6. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Mintzer S; Boppana P; Toguri J; DeSantis A Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614 [TBL] [Abstract][Full Text] [Related]
7. The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy. Heo K; Rhee Y; Lee HW; Lee SA; Shin DJ; Kim WJ; Song HK; Song K; Lee BI Epilepsia; 2011 Oct; 52(10):1884-9. PubMed ID: 21692779 [TBL] [Abstract][Full Text] [Related]
8. The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine. Serin HM; Koç ZP; Temelli B; Esen İ Epilepsy Behav; 2015 Oct; 51():221-4. PubMed ID: 26298867 [TBL] [Abstract][Full Text] [Related]
9. Adverse effects of antiepileptic drugs on bone mineral density. Babayigit A; Dirik E; Bober E; Cakmakci H Pediatr Neurol; 2006 Sep; 35(3):177-81. PubMed ID: 16939856 [TBL] [Abstract][Full Text] [Related]
10. Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy. Tsukahara H; Kimura K; Todoroki Y; Ohshima Y; Hiraoka M; Shigematsu Y; Tsukahara Y; Miura M; Mayumi M Pediatr Int; 2002 Jun; 44(3):247-53. PubMed ID: 11982890 [TBL] [Abstract][Full Text] [Related]
11. A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy. Kim SH; Lee JW; Choi KG; Chung HW; Lee HW Epilepsy Behav; 2007 Mar; 10(2):291-5. PubMed ID: 17224308 [TBL] [Abstract][Full Text] [Related]
12. Antiepileptic Drugs and Bone Health in Thai Children with Epilepsy. Paticheep S; Chotipanich C; Khusiwilai K; Wichaporn A; Khongsaengdao S J Med Assoc Thai; 2015 Jun; 98(6):535-41. PubMed ID: 26219156 [TBL] [Abstract][Full Text] [Related]
13. Effect of Long-term Carbamazepine Therapy on Bone Health. Suljic EM; Mehicevic A; Mahmutbegovic N Med Arch; 2018 Oct; 72(4):262-266. PubMed ID: 30514991 [TBL] [Abstract][Full Text] [Related]
14. Assessment of bone turnover markers and bone mineral density in normal short boys. Gayretli Aydin ZG; Bideci A; Emeksiz HC; Çelik N; Döğer E; Bukan N; Yildiz U; Camurdan OM; Cinaz P J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1321-6. PubMed ID: 26197459 [TBL] [Abstract][Full Text] [Related]
15. Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. Verrotti A; Greco R; Latini G; Morgese G; Chiarelli F Epilepsia; 2002 Dec; 43(12):1488-92. PubMed ID: 12460249 [TBL] [Abstract][Full Text] [Related]
16. [Effect of carbamazepine and valproate on bone metabolism in children with epilepsy]. Song XQ; Wang ZP; Bao KR; Zhang JM; Wu J; Yan CH; Shen XM Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):728-32. PubMed ID: 16255847 [TBL] [Abstract][Full Text] [Related]
17. Bone mineral metabolism changes in epileptic children receiving valproic acid. Oner N; Kaya M; Karasalihoğlu S; Karaca H; Celtik C; Tütüncüler F J Paediatr Child Health; 2004 Aug; 40(8):470-3. PubMed ID: 15265190 [TBL] [Abstract][Full Text] [Related]
18. Early alteration in bone metabolism in epileptic children receiving carbamazepine monotherapy owing to the induction of hepatic drug-metabolizing enzymes. Voudris KA; Attilakos A; Katsarou E; Garoufi A; Dimou S; Skardoutsou A; Mastroyianni S J Child Neurol; 2005 Jun; 20(6):513-6. PubMed ID: 15996401 [TBL] [Abstract][Full Text] [Related]
19. Vitamin D levels in children and adolescents with antiepileptic drug treatment. Baek JH; Seo YH; Kim GH; Kim MK; Eun BL Yonsei Med J; 2014 Mar; 55(2):417-21. PubMed ID: 24532512 [TBL] [Abstract][Full Text] [Related]
20. The Relationship Between Calciotropic Hormones, IGF-1, and Bone Mass Across Pubertal Stages. Matar M; Al-Shaar L; Maalouf J; Nabulsi M; Arabi A; Choucair M; Tamim H; El-Hajj Fuleihan G J Clin Endocrinol Metab; 2016 Dec; 101(12):4860-4870. PubMed ID: 27676398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]